Evolution Wealth Advisors, LLC Gilead Sciences, Inc. Transaction History

Evolution Wealth Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$64.88 - $73.64 $11,937 - $13,549	-184 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $14,350 - $15,482	-212 Reduced 53.54%	184 $13,000
Q1 2021 Apr 20, 2021	BUY	$60.0 - $68.46 $600 - $684	10 Added 2.59%	396 $26,000
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $16,995 - $19,365	-300 Reduced 43.73%	386 $22,000
Q3 2020 Oct 15, 2020	SELL	$62.1 - $78.08 $745 - $936	-12 Reduced 1.72%	686 $43,000
Q2 2020 Jul 27, 2020	BUY	$72.34 - $84.0 $15,914 - $18,480	220 Added 46.03%	698 $54,000
Q1 2020 Apr 22, 2020	SELL	$62.63 - $80.22 $582,208 - $745,725	-9,296 Reduced 95.11%	478 $36,000
Q4 2019 Feb 03, 2020	BUY	$61.62 - $67.78 $586,560 - $645,197	9,519 Added 3732.94%	9,774 $52,000
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $26,316 - $29,049	-421 Reduced 62.28%	255 $16,000
Q2 2019 Jul 12, 2019	BUY	$61.87 - $69.38 $41,824 - $46,900	676 New	676 $46,000

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.